Management of antiplatelet therapy in patients undergoing neuroendovascular procedures

Keri S Kim1, Justin F Fraser2, Stephen Grupke3

  • 11Department of Pharmacy Practice, University of Illinois Medical Center at Chicago, Illinois.

Journal of Neurosurgery
|December 2, 2017
PubMed

Insights

Neuroendovascular procedures require antiplatelet therapy to prevent clots. This review examines aspirin and clopidogrel use, guiding clinicians on managing variable patient responses to these crucial medications.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Neuroendovascular techniques are standard for cerebrovascular conditions.
  • Devices like stents and coils necessitate antiplatelet therapy.
  • Variable patient responses to aspirin and clopidogrel pose clinical challenges.

Purpose of the Study:

  • To review literature on antiplatelet use in neuroendovascular procedures.
  • To provide recommendations for managing variable antiplatelet responses.
  • To focus on clopidogrel's pharmacodynamic variability.

Main Methods:

  • Literature review of antiplatelet therapy in neuroendovascular interventions.
  • Analysis of pharmacodynamic responses to aspirin and clopidogrel.
  • Synthesis of clinical recommendations based on existing evidence.

Main Results:

  • Antiplatelet therapy is essential but exhibits significant inter-individual variability.
  • Clopidogrel response variability complicates treatment optimization.
  • Current literature highlights the need for personalized antiplatelet strategies.

Conclusions:

  • Clinicians must address variable antiplatelet responses in neuroendovascular patients.
  • Personalized antiplatelet selection, especially for clopidogrel, is critical.
  • Further research may refine antiplatelet management protocols for neuroendovascular care.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
488
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
380
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
388
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
278
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
325